Get Social

949.642.1361

949.642.1361

949.642.1361

News

Sign up now to hear Dr. Abaid speak October 29, 6pm

Patient-Focused Webinar On Paclitaxel/Carboplatin

The Foundation for Women's Cancer (FWC) hosted a webinar on Oct. 24 titled, You Got This: Getting Prepared for Paclitaxel/Carboplatin Chemotherapy. This patient-focused webinar covered how these chemotherapy drugs work; what to expect on the first day of treatment and their progress; tips and strategies to help prepare for chemotherapy treatment; and the onset and duration of side effects, and when to call their doctor. Speakers included Judith A. Smith, PharmD, BCOP, CPHQ, FCCP, FISOPP; Rebecca A. Brooks, MD and Kim Hurley—an ovarian cancer survivor whose paclitaxel/carboplatin chemotherapy treatment lasted for seven months. Click here to watch.

FDA grants priority review to olaparib for maintenance therapy of BRCA-positive ovarian cancer

The FDA granted priority review to a supplemental new drug application that seeks approval of olaparib tablets for maintenance therapy of women with newly diagnosed BRCA-mutated advanced ovarian cancer. The designation applies to use of the agent for women who are in complete or partial response after first-line standard platinum-based chemotherapy. The FDA is expected to make a decision on the application in the first quarter of 2019. Click here to read more.

Coronavirus COVID-19

Helpful Information about the Novel Coronavirus (COVID-19)

A Comprehensive Approach to Gynecologic Cancer Care

Dr. Lisa Abaid is Named Co-Director of High-Risk Breast & Ovarian Cancer Program

HPV vaccination and regular Pap screenings can greatly reduce risk of cervical cancer

Dr. Abaid discusses Genetic Screening

St. Jude Welcomes Back GOA Staff!

Copyright © 2020 Optimized360 LLC | All Rights Reserved | Privacy Policy | Terms of Use | Disclaimer | Web Accessibility Statement